ORMD 0801
0566-08-HMO-CTIL
Phase 2 small_molecule completed
Quick answer
ORMD 0801 for Brittle Type I Diabetes Mellitus is a Phase 2 program (small_molecule) at ORAMED PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ORAMED PHARMACEUTICALS INC.
- Indication
- Brittle Type I Diabetes Mellitus
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed